#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal adenocarcinoma Chronic graft versus host disease in liver Myotonia Hypotransferrinaemia Myelin oligodendrocyte glycoprotein antibody-associated disease Hepatic cirrhosis Uveitis Heart disease congenital Antiphospholipid antibodies Arginase deficiency Severe myoclonic epilepsy of infancy Chronic myelomonocytic leukaemia Lennox-Gastaut syndrome Thalassaemia Chronic hepatitis B More trials…

    Learn about Rare Diseases

    Pemphigoid – Trials in Disease Ocular melanoma Wolfram syndrome – Treatment Systemic sclerosis pulmonary – Treatment Sjogren’s syndrome – Diagnostics Combined immunodeficiency Arterial tortuosity syndrome – Life with Disease Thrombotic thrombocytopenic purpura Retinitis pigmentosa – Life with Disease Ocular melanoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Star-0215 Sodium Alginate AUROCELL-TX Anitocabtagene Autoleucel Methylprednisolone Acetate Diazepam L-Acetylleucine Galcanezumab Glibenclamide Hydroxypropyl Cellulose Lf ALXN2420 Tinzaparin Sodium Tolu Balsam Terbinafine Hydrochloride Crgd-Zw800-1 Senicapoc Mirtazapine Isoflurane Levoleucovorin Darolutamide More therapies…

    Learn about Your Condition

    Caesarean section Pancreatic failure Abdominal pain Cachexia Erythema Schizophreniform disorder Haemolytic uraemic syndrome Adenosquamous cell lung cancer Metabolic syndrome Mantle cell lymphoma recurrent Seizure Sciatica Infective uveitis Loeys-Dietz syndrome Axial spondyloarthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Ambroxol and Clenbuterol for Early Parkinson’s Disease in Patients with GBA1 Mutation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Ambroxol Hydrochloride
    • Clenbuterol Hydrochloride
    The Netherlands

  • Study on Capecitabine and Cyclophosphamide for Patients with Large Pseudomyxoma Peritonei Preparing for Surgery and Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pseudomyxoma peritonei
    Investigated Drugs:
    • Cyclophosphamide Monohydrate
    • Capecitabine
    Italy

  • Study of Metformin to Extend Pregnancy Duration in Women with Preterm Preeclampsia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Eclampsia
    • Foetal exposure during pregnancy
    • Pre-eclampsia
    Investigated Drugs:
    • Metformin Hydrochloride
    The Netherlands

  • Study Comparing mFOLFIRINOX and Capecitabine or Gemcitabine for Patients with Resected Ampullary Adenocarcinoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Tumour of ampulla of Vater
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Fluorouracil
    France

  • Study on Eptacog Alfa for Treating Acute Hemorrhagic Stroke in Patients with Brain Bleeding

    Recruiting

    3 1 1
    Investigated Diseases:
    • Haemorrhagic stroke
    Investigated Drugs:
    • Eptacog Alfa (Activated)
    Germany Spain

  • Study on the Tolerance of Intra-Articular Injection of Autologous Stromal Vascular Fraction for Adults with Thumb Arthritis (Rhizarthrosis)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Autologous Adipose Tissue-Derived Stromal Vascular Fraction
    France
Previous Page
1 … 379 380 381 382 383 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!